An appraisal of FDA approvals for adult solid tumours in 2017–2021: has the eagle landed?
Crossref DOI link: https://doi.org/10.1038/s41571-022-00636-y
Published Online: 2022-04-28
Published Print: 2022-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cherny, Nathan I. http://orcid.org/0000-0003-1976-8952
Text and Data Mining valid from 2022-04-28
Version of Record valid from 2022-04-28
Article History
Accepted: 5 April 2022
First Online: 28 April 2022
Competing interests
: N.I.C. is Chair of ESMO-MCBS working group. The author declares no financial competing interests.